U.S. Software Stock News

Gilead Sciences saw its stock slip about 3% the day after earnings. The headline factor was not weak demand, but an earnings decline driven by heavy investment. The company reported a quarterly loss of about US$10.5b and basic earnings per share of a loss of US$8.44, while base product sales reached US$7.6b with solid contributions from HIV and oncology. As a result, the stock, which had been roughly flat over the prior three months, is now trading lower. At the same time, the core drug...

Edgewell Personal Care stock closed up 2.4% at US$29.20, which suggests short term traders reacted positively to the latest update. The real story sits behind that move. Organic net sales in this consumer staples business returned to growth and adjusted earnings held firm, yet the trailing twelve months still show a loss and interest costs pressing on the income statement. For anyone looking beyond this quarter, the key issue is the tension between margin repair and balance sheet strain...

Skyward Specialty Insurance Group stock barely flinched in the red hot insurance sector playbook, adding about 2% to trade just above US$63 after earnings. That is a restrained move for a company that just put up another quarter of double digit premium growth and an operating return on equity near the high teens. Q2 delivered US$489.5m of revenue and roughly US$1.10 in basic earnings per share, while the combined ratio stayed below 90% on recent data. The key question now is whether this...

Xylem (XYL) is back in focus after releasing second quarter 2026 results and trimming its full year 2026 revenue outlook, a combination that can change how investors weigh the stock’s risk and reward. See our latest analysis for Xylem. The recent guidance trim and second quarter update come after a patchy period for Xylem, with the share price at US$122.25 and the year-to-date share price return down 10.84%, even as the 3-year total shareholder return of 23.93% points to a stronger longer-run...

Postal Realty Trust stock inched up 0.9% to US$23.33 into the close, a calm move for a real estate investment trust that just posted a very loud message on earnings power. The headline is simple: Adjusted funds from operations per share, the core cash earnings metric for REITs, came in at US$0.36 and management nudged full year guidance higher while keeping leverage in check. The market treated today as business as usual. The numbers point to a stronger story building quietly underneath that...

Central Bancompany stock barely flinched after a strong quarter, slipping less than 1% to about $33 even as earnings and margins quietly did the heavy lifting. That muted move sits awkwardly beside another clean beat on the core banking levers that matter most. The real headline is profit quality and spread power. Net income reached $113.8m with basic earnings per share near $0.47, supported by a full tax equivalent net interest margin of 4.43% and a return on average assets of 2.24%. For a...

Talos Energy stock barely flinched after earnings, slipping only 0.6% to about $14. That muted move sits awkwardly against a quarter built on record adjusted free cash flow of about $232 million and adjusted earnings before interest, tax, depreciation and amortization above $400 million. For a company that has carried losses over the past year, this profit snapback grabs attention. The short term price shrug leaves you with the real question: Are these cash rich production numbers and low...

Griffon stock just rose almost 10% in a single session, and the move revolves around one thing: the market is rushing to reprice the profit story, not the top line. Adjusted earnings per share from continuing operations came in at about US$1.51 for the quarter on US$481.37m of revenue, while adjusted EBITDA held a margin near 26%. That mix of solid earnings power and firm margins in a soft housing and construction backdrop is what traders focused on. The question now is whether this one-day...

ACADIA Pharmaceuticals stock jumped 6.1% to US$28.80 after earnings, capping a strong run over the past three months. The move lines up with what the numbers signal. Q2 2026 revenue reached US$307.96 million and net income was US$31.5 million, keeping ACADIA on a solid profitability footing. Yet the real story for anyone thinking beyond this quarter is how that improving earnings base sits against a P/E of 13 and a discounted cash flow estimate of US$87.67 per share. The short term is...

Primo Brands came into this print looking like a puzzle. The stock had barely moved over the past month, yet investors were paying a premium P/E multiple for a water and beverage business. Then Q2 landed and the market snapped awake, with the share price jumping 8.7% on the day. The headline is simple: earnings power is starting to catch up with the valuation story. Primo Brands delivered Q2 net income from continuing operations of US$111.7m on a trailing twelve month basis and Q2 adjusted...

Clear Channel Outdoor Holdings shares barely moved on the print, slipping just 0.4% to US$2.42, yet the quarter itself was anything but flat. Investors who bought into the long running recovery thesis are now facing a different story. The headline is a much smaller loss on a much larger revenue base, with Q2 revenue at US$438.0m and net loss from ongoing operations sharply lower than earlier quarters. The expectation gap is clear. The stock is trading as if nothing changed, while the income...

BioCryst Pharmaceuticals stock barely moved on the day, closing at US$9.07 and up just 0.6%, which suggests the market is still unsure how to price this rare disease story. The headline from Q2 is clear. BioCryst flipped from a heavy loss in Q1 to a quarterly profit, with basic earnings per share of US$0.31 on total revenue of US$218.25 million. For short term traders that muted price action might feel underwhelming. For investors looking at the next few years, the combination of profitable...

AGNT shares slipped 4% today to close at US$4.05, even as the company reported what management called a record quarter on the top line. That tension between red on the screen and improving income statement detail is the core story. Revenue reached about US$1.45b in Q2, while basic earnings per share loss narrowed to roughly US$0.02. Adjusted EBITDA moved into more meaningful territory as well. The market focused on the red ink and recent price weakness, but the earnings report points to a...

The market just put Advanced Micro Devices in the penalty box, with the stock dropping about 7% to roughly US$482, even though the core earnings story landed far from weak. Q2 revenue came in at US$11.5b and non GAAP gross margin reached 56%, both pointing to a company leaning hard into high value data center and artificial intelligence compute demand. Short term traders focused on the rich P/E and recent volatility. Longer term investors are likely asking a different question: Is this...

Hinge Health came into this print with a mixed setup for investors. The stock was up almost 47% over the past three months yet had slipped about 9% over the past month. After the Q2 release, shares added another 1.7%, a modest move given the strength of the results. The real headline was profitability. Hinge Health posted Q2 revenue of about US$213m with operating income of US$62m and free cash flow of US$100m. In digital musculoskeletal care, that kind of revenue scale, paired with a near...

Cummins (CMI) reported record second quarter 2026 results, with sales of US$9.46b and net income of US$932m, and raised its full year revenue growth guidance to a range of 10% to 13%. See our latest analysis for Cummins. Following these results and the raised guidance, Cummins shares have shown firm momentum, with a 7-day share price return of 7.30% and a year to date share price return of 24.56%. The 1-year total shareholder return of 73.09% and 5-year total shareholder return of 202.33%...

Astec Industries holders just watched the stock fall almost 14% in a single session, even though the company reported record quarterly revenue of US$408.1m and record adjusted earnings before interest, tax, depreciation and amortization of US$42.6m. That clash between price action and headline numbers is the story today. Coming into this report, the stock had already slipped over the past month. The fresh drop reflects that the market is fixated on the trimmed full year adjusted EBITDA...

Glacier Bancorp stock slipped about 1.9% to US$50 after the Q2 release, which looks cautious given how strong the core banking engine just ran. For a bank that many investors see as a steady regional compounder, the headline is about profitability, not drama. Net interest margin, the key spread between what Glacier Bancorp earns on loans and pays on funding, reached 3.9%. Pretax preprovision net revenue climbed to US$130.8m as costs stayed in check. The market marked the shares down. The...

BNCCORP stock barely budged after earnings, up just 0.6% to US$36.25, yet the quarter quietly sharpened the core banking story. The headline is not the share price. It is that BNCCORP generated Q2 basic EPS of US$0.54 on revenue of US$10.81m, while carrying a trailing P/E of 14.4x that sits below both the broader US market and peer bank averages. That gap between muted price action and a relatively low earnings multiple is what matters most today. It frames how you judge this mid sized...

Enova International (ENVA) is back in focus after reporting second quarter 2026 results that show higher revenue, higher net income and higher earnings per share compared with the same period last year. See our latest analysis for Enova International. The strong second quarter report and ongoing share repurchases appear to be feeding into a powerful share price trend for Enova International, with a 90 day share price return of 52.48% and a 1 year total shareholder return of 152.15%. This...

Charles River Laboratories International jumped 11.4% to US$260.72 on Wednesday as investors rushed to reprice a story that now looks less about survival and more about repair. The headline is simple. Q2 non GAAP earnings came in strong enough for management to lift full year earnings guidance and discuss a cleaner portfolio and better margin run rate. Short term traders see a sharp move in a stock that had already logged a solid 90 day run. Longer term holders are now weighing that rally...

TAT Technologies stock closed up 2.3% at US$42.62, a modest move for what looked like a far louder earnings message. The crowd traded it like just another decent quarter. The numbers told a different story. Revenue reached US$52.9m in the quarter and operating income stood at US$5.6m, both supported by record long term agreements and backlog in the US$615m to US$650m range. The market reaction looked contained while the core aviation services engine behind TAT Technologies quietly ran much...

NexPoint Residential Trust shares inched up 1.4% to US$24.76, a modest bounce that sits awkwardly against a year of double digit declines. The mood today looks more like a sigh of relief than a victory lap. Core funds from operations, or core FFO, landed at US$0.66 per share and edged past expectations, while full year core FFO guidance was cut to a midpoint of US$2.45. The market appears to be cheering the small beat and shrugging at the guidance cut that is tied to higher interest expense...

Red Rock Resorts stock just dropped 5.1% to close at US$60.97, yet the earnings story is more about pressure than collapse. Q2 revenue came in at US$510.3m while net income reached US$39.1m, and the real headline is margin compression as adjusted EBITDA margins stepped down across the Las Vegas locals portfolio. Coming into today, the stock already sat modestly weaker over the past month and week. This selloff reflects investors finally pricing in a clear squeeze on profitability rather than...